| Dopaminergic synapse |
2.02 |
1.25e-2 |
115/132 (87.12%) |
CREB1;GNB2;GNAS;...
|
| Endocrine and other factor-regulated calcium reabsorpti... |
2.01 |
6.23e-3 |
49/53 (92.45%) |
DNM1;GNAS;PRKCA;...
|
| Inositol phosphate metabolism |
1.97 |
8.31e-3 |
66/73 (90.41%) |
IMPA2;PLCE1;CDIPT;...
|
| Circadian entrainment |
1.91 |
2.80e-2 |
85/97 (87.63%) |
CREB1;GNB2;GNAS;...
|
| Histidine metabolism |
1.86 |
2.74e-2 |
16/22 (72.73%) |
ALDH2;MAOA;HNMT;...
|
| Gastric acid secretion |
1.86 |
2.49e-2 |
63/76 (82.89%) |
GNAS;KCNJ15;PRKCA;...
|
| Cholinergic synapse |
1.85 |
2.14e-2 |
99/113 (87.61%) |
CREB1;GNB2;PRKCA;...
|
| Insulin secretion |
1.81 |
2.65e-2 |
75/86 (87.21%) |
SNAP25;CREB1;TRPM4;...
|
| Vibrio cholerae infection |
1.80 |
2.77e-2 |
44/50 (88%) |
ATP6V0E2;GNAS;PRKCA;...
|
| Pentose phosphate pathway |
1.80 |
2.99e-2 |
25/30 (83.33%) |
PGLS;PFKM;GPI;...
|
| Lysosome |
1.77 |
3.51e-2 |
115/128 (89.84%) |
GALC;ACP2;TPP1;...
|
| Valine, leucine and isoleucine degradation |
1.76 |
3.74e-2 |
42/48 (87.5%) |
ALDH2;ALDH6A1;DLD;...
|
| Glutamatergic synapse |
1.76 |
3.64e-2 |
97/114 (85.09%) |
GNB2;GNAS;PRKCA;...
|
| Serotonergic synapse |
1.76 |
3.56e-2 |
97/114 (85.09%) |
ALOX5;GNB2;GNAS;...
|
| Leishmaniasis |
1.74 |
3.57e-2 |
67/77 (87.01%) |
MARCKSL1;HLA-DPB1;TLR4;...
|
| Propanoate metabolism |
1.74 |
3.35e-2 |
30/34 (88.24%) |
SUCLG2;ALDH6A1;DLD;...
|
| Axon guidance |
1.73 |
3.37e-2 |
151/182 (82.97%) |
EPHB2;CXCL12;SEMA5A;...
|
| Phosphatidylinositol signaling system |
1.72 |
3.32e-2 |
82/97 (84.54%) |
IMPA2;PLCE1;CDIPT;...
|
| Amphetamine addiction |
1.71 |
3.34e-2 |
57/69 (82.61%) |
CREB1;GNAS;PRKCA;...
|
| Glucagon signaling pathway |
1.68 |
3.92e-2 |
89/107 (83.18%) |
CREB1;PFKM;PYGL;...
|
| Aldosterone-regulated sodium reabsorption |
1.68 |
3.86e-2 |
34/37 (91.89%) |
PRKCA;ATP1B1;SCNN1A;...
|
| Peroxisome |
1.66 |
4.08e-2 |
72/82 (87.8%) |
GSTK1;PHYH;ECH1;...
|
| Melanogenesis |
1.66 |
4.01e-2 |
74/101 (73.27%) |
CREB1;FZD2;GNAS;...
|
| Asthma |
1.66 |
3.89e-2 |
25/31 (80.65%) |
HLA-DPB1;HLA-DRA;HLA-DPA1;...
|
| Growth hormone synthesis, secretion and action |
1.65 |
3.94e-2 |
108/119 (90.76%) |
CREB1;IRS2;GHR;...
|
| Sulfur relay system |
1.65 |
3.98e-2 |
5/8 (62.5%) |
TST;MPST
|
| Sulfur metabolism |
1.65 |
3.83e-2 |
9/10 (90%) |
TST;SELENBP1;MPST;...
|
| Other glycan degradation |
1.64 |
3.78e-2 |
13/18 (72.22%) |
FUCA1;MANBA;GLB1;...
|
| Fc gamma R-mediated phagocytosis |
1.64 |
3.91e-2 |
79/97 (81.44%) |
MARCKSL1;PLPP2;PRKCA;...
|
| Cocaine addiction |
1.63 |
4.02e-2 |
42/49 (85.71%) |
CREB1;GNAS;MAOA;...
|
| NF-kappa B signaling pathway |
-1.65 |
3.85e-2 |
90/104 (86.54%) |
PIDD1;BCL2L1;VCAM1;...
|
| Rheumatoid arthritis |
-1.72 |
1.34e-2 |
78/93 (83.87%) |
ATP6V1G1;ANGPT1;TEK;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
-1.75 |
1.10e-2 |
62/70 (88.57%) |
CDC42;NFKBIA;NFKB1;...
|
| Lipid and atherosclerosis |
-1.78 |
9.37e-3 |
190/215 (88.37%) |
HSPA5;LDLR;ICAM1;...
|
| Fluid shear stress and atherosclerosis |
-1.80 |
5.45e-3 |
123/139 (88.49%) |
SUMO4;ITGAV;NFKB1;...
|
| Prion disease |
-1.83 |
4.50e-3 |
209/273 (76.56%) |
PSMA7;ADRM1;ATP5F1C;...
|
| TNF signaling pathway |
-1.90 |
8.33e-4 |
103/112 (91.96%) |
RIPK1;MAP2K3;LTA;...
|
| Viral protein interaction with cytokine and cytokine re... |
-1.93 |
0.00e+0 |
84/100 (84%) |
IL2;TNFRSF10B;LTA;...
|
| Spliceosome |
-1.97 |
0.00e+0 |
101/150 (67.33%) |
MAGOH;SNRNP27;PRPF38B;...
|
| Ribosome |
-2.02 |
0.00e+0 |
113/158 (71.52%) |
MRPL24;RPSA;RPL21;...
|
| RNA transport |
-2.02 |
0.00e+0 |
128/186 (68.82%) |
EIF1AX;RANBP2;MAGOH;...
|
| Ribosome biogenesis in eukaryotes |
-2.07 |
0.00e+0 |
52/108 (48.15%) |
NOP10;GAR1;REXO5;...
|
| Proteasome |
-2.08 |
0.00e+0 |
44/46 (95.65%) |
PSMC3;PSMD8;PSMA7;...
|
| Legionellosis |
-2.22 |
0.00e+0 |
51/57 (89.47%) |
TNF;IL1B;IL18;...
|
| IL-17 signaling pathway |
-2.29 |
0.00e+0 |
84/94 (89.36%) |
MUC5B;HSP90B1;S100A7;...
|
